The New York Entrepreneur

Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge

Read Time:7 Second

The results come amid investor anxiety over the thousands of lawsuits claiming that J&J’s talc-based baby powder and other products caused cancer.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post American Airlines raises 2023 profit forecast after strong second quarter
Next post Crypto price prediction: Arkham (ARKM) and AltSignals (ASI)